Neumora Therapeutics Inc (NMRA) Stock: Navigating a Year of Stock Volatility

THMO

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Neumora Therapeutics Inc’s current trading price is -95.61% away from its 52-week high, while its distance from the 52-week low is 23.50%. The stock’s price range during this period has varied between $0.61 and $17.19. The company, active in the Healthcare sector, saw a trading volume of around 1.35 million for the day, considerably higher average daily volume of 1.12 million observed over the last three months.

Neumora Therapeutics Inc’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $17.19 on 10/18/24, and the lowest price during that time was $0.61, recorded on 05/14/25.

How Financial Performance Impacts Market Capitalization

Neumora Therapeutics Inc (NMRA) has experienced a quarterly decline of -55.87% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 122.06M and boasts a workforce of 110 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.7303, with a change in price of -9.8754. Similarly, Neumora Therapeutics Inc recorded 2,389,756 in trading volume during the last 100 days, posting a change of -92.90%.

How NMRA’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for NMRA stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

NMRA Stock Stochastic Average

As of today, the raw stochastic average of Neumora Therapeutics Inc over the past 50 days is 16.54%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 76.02%. Additionally, the Stochastic %K and %D values for the company were 59.39% and 49.22%, respectively, over the past 20 days.

NMRA Stock Price Performance Analysis

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price decrease of -92.88%. However, over the past six months, we’ve seen a stronger performance of -93.04%. The price of NMRA fallen by 7.04% over the last 30 days. And in the last five days, it has surged by 22.68%.

Most Popular

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.